Herold J. Metselaar

13.3k total citations
250 papers, 7.8k citations indexed

About

Herold J. Metselaar is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Herold J. Metselaar has authored 250 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Hepatology, 102 papers in Surgery and 84 papers in Epidemiology. Recurrent topics in Herold J. Metselaar's work include Organ Transplantation Techniques and Outcomes (81 papers), Liver Disease and Transplantation (79 papers) and Renal Transplantation Outcomes and Treatments (48 papers). Herold J. Metselaar is often cited by papers focused on Organ Transplantation Techniques and Outcomes (81 papers), Liver Disease and Transplantation (79 papers) and Renal Transplantation Outcomes and Treatments (48 papers). Herold J. Metselaar collaborates with scholars based in Netherlands, China and United States. Herold J. Metselaar's co-authors include Hugo W. Tilanus, Luc J. W. van der Laan, Jaap Kwekkeboom, Geert Kazemier, Jan N.M. IJzermans, Qiuwei Pan, Jeroen de Jonge, Maikel P. Peppelenbosch, Robert A. de Man and T. Tha‐In and has published in prestigious journals such as Blood, Annals of Internal Medicine and The Journal of Immunology.

In The Last Decade

Herold J. Metselaar

244 papers receiving 7.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Herold J. Metselaar Netherlands	49	3.3k	2.9k	2.1k	1.4k	1.2k	250	7.8k
Kareem Abu‐Elmagd United States	58	2.6k 0.8×	7.2k 2.4×	1.9k 0.9×	3.7k 2.7×	1.1k 0.9×	335	11.9k
Tak Mao Chan Hong Kong	57	2.2k 0.7×	1.5k 0.5×	2.2k 1.0×	614 0.4×	3.1k 2.5×	442	13.2k
Piergiorgio Messa Italy	48	2.6k 0.8×	849 0.3×	2.4k 1.1×	697 0.5×	938 0.8×	330	7.9k
Manuel Pascual Switzerland	53	1.4k 0.4×	3.3k 1.1×	2.7k 1.3×	4.3k 3.2×	2.2k 1.8×	266	10.6k
Douglas G. Farmer United States	60	6.5k 2.0×	6.9k 2.3×	3.3k 1.6×	1.7k 1.2×	577 0.5×	234	11.1k
John A. Goss United States	46	2.1k 0.6×	3.8k 1.3×	1.2k 0.6×	776 0.6×	475 0.4×	223	6.2k
L Makowka United States	54	4.9k 1.5×	6.1k 2.1×	2.9k 1.4×	1.6k 1.2×	822 0.7×	308	10.5k
Sandy Feng United States	51	5.7k 1.7×	6.5k 2.2×	2.9k 1.4×	3.5k 2.5×	546 0.4×	146	10.9k
Keith Rolles United Kingdom	48	4.1k 1.3×	4.0k 1.4×	2.9k 1.4×	1.6k 1.2×	374 0.3×	199	8.3k
Ignazio R. Marino United States	46	2.6k 0.8×	2.9k 1.0×	2.6k 1.2×	1.1k 0.8×	318 0.3×	216	6.3k

Countries citing papers authored by Herold J. Metselaar

Since Specialization

Citations

This map shows the geographic impact of Herold J. Metselaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herold J. Metselaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herold J. Metselaar more than expected).

Fields of papers citing papers by Herold J. Metselaar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herold J. Metselaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herold J. Metselaar. The network helps show where Herold J. Metselaar may publish in the future.

Co-authorship network of co-authors of Herold J. Metselaar

This figure shows the co-authorship network connecting the top 25 collaborators of Herold J. Metselaar. A scholar is included among the top collaborators of Herold J. Metselaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herold J. Metselaar. Herold J. Metselaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Metselaar, Herold J., Bart van Hoek, Caroline M. den Hoed, et al.. (2024). Long-term maternal outcomes of pregnancy after orthotopic liver transplantation in the Netherlands: A retrospective multicenter cohort study. Liver Transplantation. 31(4). 508–520.

Hoek, Bart van, Ian P.J. Alwayn, Brenda C. M. de Winter, et al.. (2024). Modifying Tacrolimus-related Toxicity After Liver Transplantation Comparing Life Cycle Pharma Tacrolimus Versus Extended-released Tacrolimus: A Multicenter, Randomized Controlled Trial. Transplantation Direct. 10(4). e1612–e1612. 1 indexed citations

Busschbach, Jan J.V., Bart van Hoek, Aad P. van den Berg, et al.. (2023). Health-related Quality of Life and Fatigue in Liver Transplant Recipients Receiving Tacrolimus Versus Sirolimus-based Immunosuppression: Results From a Randomized Trial. Transplantation. 107(12). 2545–2553. 2 indexed citations

Kho, Marcia M. L., Dominique M. Bovée, Herold J. Metselaar, et al.. (2021). Herpes Zoster in Solid Organ Transplantation: Incidence and Risk Factors. Frontiers in Immunology. 12. 645718–645718. 19 indexed citations

Roos, Floris J.M., Marcel J. C. Bijvelds, Monique M.A. Verstegen, et al.. (2021). Impact of hypoxia and AMPK on CFTR-mediated bicarbonate secretion in human cholangiocyte organoids. American Journal of Physiology-Gastrointestinal and Liver Physiology. 320(5). G741–G752. 8 indexed citations

Berenguer, Marina, Patrizia Burra, R. Mark Ghobrial, et al.. (2020). Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference. Transplantation. 104(6). 1143–1149. 44 indexed citations

Jansen, Jos C., Bart van Hoek, Herold J. Metselaar, et al.. (2020). Screening for abnormal glycosylation in a cohort of adult liver disease patients. Journal of Inherited Metabolic Disease. 43(6). 1310–1320. 8 indexed citations

Erler, Nicole S., et al.. (2020). Identification and prognostic impact of malnutrition in a population screened for liver transplantation. Clinical Nutrition ESPEN. 36. 36–44. 8 indexed citations

Bouma, Margriet, David M. Burger, Joost P.H. Drenth, et al.. (2018). Safe use of proton pump inhibitors in patients with cirrhosis. British Journal of Clinical Pharmacology. 84(8). 1806–1820. 35 indexed citations

10.

Verstegen, Monique M.A., Jorke Willemse, Gert‐Jan Kremers, et al.. (2017). Decellularization of Whole Human Liver Grafts Using Controlled Perfusion for Transplantable Organ Bioscaffolds. Stem Cells and Development. 26(18). 1304–1315. 68 indexed citations

11.

Vugt, Jeroen L.A. van, Stefan Buettner, Louise J. M. Alferink, et al.. (2017). Low skeletal muscle mass is associated with increased hospital costs in patients with cirrhosis listed for liver transplantation-a retrospective study. Transplant International. 31(2). 165–174. 65 indexed citations

12.

Yin, Yuebang, Yijin Wang, Wen Dang, et al.. (2016). Mycophenolic acid potently inhibits rotavirus infection with a high barrier to resistance development. Antiviral Research. 133. 41–49. 46 indexed citations

13.

Mancham, Shanta, Monique M.A. Verstegen, Petra E. de Ruiter, et al.. (2015). Human Graft-Derived Mesenchymal Stromal Cells Potently Suppress Alloreactive T-Cell Responses. Stem Cells and Development. 24(12). 1436–1447. 20 indexed citations

14.

Fouraschen, Suomi M.G., Qiuwei Pan, Petra E. de Ruiter, et al.. (2012). Secreted Factors of Human Liver-Derived Mesenchymal Stem Cells Promote Liver Regeneration Early After Partial Hepatectomy. Stem Cells and Development. 21(13). 2410–2419. 82 indexed citations

15.

Boor, Patrick P.C., et al.. (2011). Human plasmacytoid dendritic cells induce CD8⁺LAG‐3⁺Foxp3⁺CTLA‐4⁺ regulatory T cells that suppress allo‐reactive memory T cells. European Journal of Immunology. 41(6). 1663–1674. 43 indexed citations

16.

Kuiper, Edith M.M., Bettina E. Hansen, Herold J. Metselaar, et al.. (2010). Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008. BMC Gastroenterology. 10(1). 144–144. 29 indexed citations

17.

Metselaar, Herold J., Nicole M. van Besouw, Shanta Mancham, et al.. (2009). Migration of allosensitizing donor myeloid dendritic cells into recipients after liver transplantation. Liver Transplantation. 16(1). 12–22. 14 indexed citations

18.

Henry, Scot D., et al.. (2007). University of Wisconsin solution enhances gene therapy vector delivery under hypo- and normo-thermic conditions.. American Journal of Transplantation. 7. 437–437. 1 indexed citations

19.

Reuver, Philip de, Vera Pravica, Wim C.J. Hop, et al.. (2003). Recipient CTLA-4 +49 G/G Genotype Is Associated with Reduced Incidence of Acute Rejection After Liver Transplantation. American Journal of Transplantation. 3(12). 1587–1594. 35 indexed citations

20.

Baan, Carla C., Cécile Holweg, Teun van Gelder, et al.. (1999). The macrophage-derived T-Cell growth factor interleukin-15 is present in interleukin-2–independent rejection after clinical heart and liver transplantation. Transplantation Proceedings. 31(7). 2726–2728. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact